APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceutical Oral Drug Delivery

Compare research editions
View pricing & licenses

Selected research

Industry Research

Biopharmaceutical Oral Drug Delivery Industry Research Report 2026

23 December 2025126 pages

Choose your research edition.

Industry ResearchBiopharmaceutical Oral Drug Delivery Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceutical Oral Drug Delivery Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Biopharmaceutical Oral Drug Delivery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceutical Oral Drug Delivery Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceutical Oral Drug Delivery Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Biopharmaceutical Oral Drug Delivery market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Biopharmaceutical Oral Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Biopharmaceutical Oral Drug Delivery is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Biopharmaceutical Oral Drug Delivery is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Biopharmaceutical Oral Drug Delivery include Sanofi, Novartis, Novo Nordisk, Pfizer, Amgen, AbbVie, Kemwell Bipharma, F. Hoffman-La Roche and Catalent, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Biopharmaceutical Oral Drug Delivery market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Biopharmaceutical Oral Drug Delivery Market by Company

Sanofi

Novartis

Novo Nordisk

Pfizer

Amgen

AbbVie

Kemwell Bipharma

F. Hoffman-La Roche

Catalent

Biocon

Biopharmaceutical Oral Drug Delivery Segment by Type

Normally Protein (Antibodies)

Nucleic Acids (DNA, RNA Or Oligonucleotides)

Biopharmaceutical Oral Drug Delivery Segment by Application

Retail Pharmacy

Hospital Pharmacy

Specialty Pharmacy

Biopharmaceutical Oral Drug Delivery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical Oral Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical Oral Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical Oral Drug Delivery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Biopharmaceutical Oral Drug Delivery manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Biopharmaceutical Oral Drug Delivery by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Biopharmaceutical Oral Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Biopharmaceutical Oral Drug Delivery Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Biopharmaceutical Oral Drug Delivery Sales (k units) of Manufacturers (2021-2026) Table 7. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Manufacturers (2021-2026) Table 8. Global Biopharmaceutical Oral Drug Delivery Revenue of Manufacturers (2021-2026) Table 9. Global Biopharmaceutical Oral Drug Delivery Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Biopharmaceutical Oral Drug Delivery Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Biopharmaceutical Oral Drug Delivery Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Biopharmaceutical Oral Drug Delivery, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Biopharmaceutical Oral Drug Delivery, Product Type & Application Table 14. Global Biopharmaceutical Oral Drug Delivery Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Biopharmaceutical Oral Drug Delivery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Sanofi Company Information Table 19. Sanofi Business Overview Table 20. Sanofi Biopharmaceutical Oral Drug Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Sanofi Biopharmaceutical Oral Drug Delivery Product Portfolio Table 22. Sanofi Recent Developments Table 23. Novartis Company Information Table 24. Novartis Business Overview Table 25. Novartis Biopharmaceutical Oral Drug Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Novartis Biopharmaceutical Oral Drug Delivery Product Portfolio Table 27. Novartis Recent Developments Table 28. Novo Nordisk Company Information Table 29. Novo Nordisk Business Overview Table 30. Novo Nordisk Biopharmaceutical Oral Drug Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Novo Nordisk Biopharmaceutical Oral Drug Delivery Product Portfolio Table 32. Novo Nordisk Recent Developments Table 33. Pfizer Company Information Table 34. Pfizer Business Overview Table 35. Pfizer Biopharmaceutical Oral Drug Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Pfizer Biopharmaceutical Oral Drug Delivery Product Portfolio Table 37. Pfizer Recent Developments Table 38. Amgen Company Information Table 39. Amgen Business Overview Table 40. Amgen Biopharmaceutical Oral Drug Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Amgen Biopharmaceutical Oral Drug Delivery Product Portfolio Table 42. Amgen Recent Developments Table 43. AbbVie Company Information Table 44. AbbVie Business Overview Table 45. AbbVie Biopharmaceutical Oral Drug Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. AbbVie Biopharmaceutical Oral Drug Delivery Product Portfolio Table 47. AbbVie Recent Developments Table 48. Kemwell Bipharma Company Information Table 49. Kemwell Bipharma Business Overview Table 50. Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Product Portfolio Table 52. Kemwell Bipharma Recent Developments Table 53. F. Hoffman-La Roche Company Information Table 54. F. Hoffman-La Roche Business Overview Table 55. F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Product Portfolio Table 57. F. Hoffman-La Roche Recent Developments Table 58. Catalent Company Information Table 59. Catalent Business Overview Table 60. Catalent Biopharmaceutical Oral Drug Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Catalent Biopharmaceutical Oral Drug Delivery Product Portfolio Table 62. Catalent Recent Developments Table 63. Biocon Company Information Table 64. Biocon Business Overview Table 65. Biocon Biopharmaceutical Oral Drug Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Biocon Biopharmaceutical Oral Drug Delivery Product Portfolio Table 67. Biocon Recent Developments Table 68. Global Biopharmaceutical Oral Drug Delivery Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 69. Global Biopharmaceutical Oral Drug Delivery Sales by Region (2021-2026) & (k units) Table 70. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Region (2021-2026) Table 71. Global Biopharmaceutical Oral Drug Delivery Sales by Region (2027-2032) & (k units) Table 72. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Region (2027-2032) Table 73. Global Biopharmaceutical Oral Drug Delivery Revenue by Region (2021-2026) & (US$ Million) Table 74. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Region (2021-2026) Table 75. Global Biopharmaceutical Oral Drug Delivery Revenue by Region (2027-2032) & (US$ Million) Table 76. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Region (2027-2032) Table 77. North America Biopharmaceutical Oral Drug Delivery Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. North America Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2026) & (k units) Table 79. North America Biopharmaceutical Oral Drug Delivery Sales by Country (2027-2032) & (k units) Table 80. North America Biopharmaceutical Oral Drug Delivery Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Biopharmaceutical Oral Drug Delivery Revenue by Country (2027-2032) & (US$ Million) Table 82. Europe Biopharmaceutical Oral Drug Delivery Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Europe Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2026) & (k units) Table 84. Europe Biopharmaceutical Oral Drug Delivery Sales by Country (2027-2032) & (k units) Table 85. Europe Biopharmaceutical Oral Drug Delivery Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe Biopharmaceutical Oral Drug Delivery Revenue by Country (2027-2032) & (US$ Million) Table 87. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2026) & (k units) Table 89. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Country (2027-2032) & (k units) Table 90. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue by Country (2021-2026) & (US$ Million) Table 91. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue by Country (2027-2032) & (US$ Million) Table 92. South America Biopharmaceutical Oral Drug Delivery Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. South America Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2026) & (k units) Table 94. South America Biopharmaceutical Oral Drug Delivery Sales by Country (2027-2032) & (k units) Table 95. South America Biopharmaceutical Oral Drug Delivery Revenue by Country (2021-2026) & (US$ Million) Table 96. South America Biopharmaceutical Oral Drug Delivery Revenue by Country (2027-2032) & (US$ Million) Table 97. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2026) & (k units) Table 99. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Country (2027-2032) & (k units) Table 100. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue by Country (2021-2026) & (US$ Million) Table 101. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue by Country (2027-2032) & (US$ Million) Table 102. Global Biopharmaceutical Oral Drug Delivery Sales by Type (2021-2026) & (k units) Table 103. Global Biopharmaceutical Oral Drug Delivery Sales by Type (2027-2032) & (k units) Table 104. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2021-2026) Table 105. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2027-2032) Table 106. Global Biopharmaceutical Oral Drug Delivery Revenue by Type (2021-2026) & (US$ Million) Table 107. Global Biopharmaceutical Oral Drug Delivery Revenue by Type (2027-2032) & (US$ Million) Table 108. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2021-2026) Table 109. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2027-2032) Table 110. Global Biopharmaceutical Oral Drug Delivery Price by Type (2021-2026) & (US$/unit) Table 111. Global Biopharmaceutical Oral Drug Delivery Price by Type (2027-2032) & (US$/unit) Table 112. Global Biopharmaceutical Oral Drug Delivery Sales by Application (2021-2026) & (k units) Table 113. Global Biopharmaceutical Oral Drug Delivery Sales by Application (2027-2032) & (k units) Table 114. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2021-2026) Table 115. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2027-2032) Table 116. Global Biopharmaceutical Oral Drug Delivery Revenue by Application (2021-2026) & (US$ Million) Table 117. Global Biopharmaceutical Oral Drug Delivery Revenue by Application (2027-2032) & (US$ Million) Table 118. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2021-2026) Table 119. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2027-2032) Table 120. Global Biopharmaceutical Oral Drug Delivery Price by Application (2021-2026) & (US$/unit) Table 121. Global Biopharmaceutical Oral Drug Delivery Price by Application (2027-2032) & (US$/unit) Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Biopharmaceutical Oral Drug Delivery Distributors List Table 125. Biopharmaceutical Oral Drug Delivery Customers List Table 126. Biopharmaceutical Oral Drug Delivery Industry Trends Table 127. Biopharmaceutical Oral Drug Delivery Industry Drivers Table 128. Biopharmaceutical Oral Drug Delivery Industry Restraints Table 129. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Biopharmaceutical Oral Drug Delivery Product Image Figure 5. Global Biopharmaceutical Oral Drug Delivery Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Biopharmaceutical Oral Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 7. Global Biopharmaceutical Oral Drug Delivery Sales (2021-2032) & (k units) Figure 8. Global Biopharmaceutical Oral Drug Delivery Average Price (US$/unit) & (2021-2032) Figure 9. Normally Protein (Antibodies) Product Image Figure 10. Nucleic Acids (DNA, RNA Or Oligonucleotides) Product Image Figure 11. Retail Pharmacy Product Image Figure 12. Hospital Pharmacy Product Image Figure 13. Specialty Pharmacy Product Image Figure 14. Global Biopharmaceutical Oral Drug Delivery Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Biopharmaceutical Oral Drug Delivery, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Biopharmaceutical Oral Drug Delivery Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Biopharmaceutical Oral Drug Delivery Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Biopharmaceutical Oral Drug Delivery Sales by Region in 2025 Figure 20. Global Biopharmaceutical Oral Drug Delivery Revenue by Region in 2025 Figure 21. North America Biopharmaceutical Oral Drug Delivery Market Size by Country in 2025 Figure 22. North America Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2021-2032) Figure 23. North America Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country (2021-2032) Figure 24. United States Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Biopharmaceutical Oral Drug Delivery Market Size by Country in 2025 Figure 28. Europe Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2021-2032) Figure 29. Europe Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country (2021-2032) Figure 30. Germany Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Biopharmaceutical Oral Drug Delivery Market Size by Country in 2025 Figure 41. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country (2021-2032) Figure 43. China Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Biopharmaceutical Oral Drug Delivery Market Size by Country in 2025 Figure 52. South America Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2021-2032) Figure 53. South America Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country (2021-2032) Figure 54. Brazil Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Biopharmaceutical Oral Drug Delivery Market Size by Country in 2025 Figure 59. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country (2021-2032) Figure 61. Egypt Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2021-2032) Figure 67. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2021-2032) Figure 68. Global Biopharmaceutical Oral Drug Delivery Price (US$/unit) by Type (2021-2032) Figure 69. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2021-2032) Figure 70. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2021-2032) Figure 71. Global Biopharmaceutical Oral Drug Delivery Price (US$/unit) by Application (2021-2032) Figure 72. Biopharmaceutical Oral Drug Delivery Value Chain Figure 73. Biopharmaceutical Oral Drug Delivery Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Biopharmaceutical Oral Drug Delivery Industry Opportunities and Challenges

Scope & coverage.

Types
  • Normally Protein (Antibodies)
  • Nucleic Acids (DNA, RNA Or Oligonucleotides)
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Specialty Pharmacy
Companies covered
  • Sanofi
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Amgen
  • AbbVie
  • Kemwell Bipharma
  • F. Hoffman-La Roche
  • Catalent
  • Biocon

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Biopharmaceutical Oral Drug Delivery Market Size (2021-2032)
  4. 2.2.2 Global Biopharmaceutical Oral Drug Delivery Sales (2021-2032)
  5. 2.2.3 Global Biopharmaceutical Oral Drug Delivery Market Average Price (2021-2032)
  6. 2.3 Biopharmaceutical Oral Drug Delivery by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Normally Protein (Antibodies)
  9. 2.3.3 Nucleic Acids (DNA, RNA Or Oligonucleotides)
  10. 2.4 Biopharmaceutical Oral Drug Delivery by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Retail Pharmacy
  13. 2.4.3 Hospital Pharmacy
  14. 2.4.4 Specialty Pharmacy
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Biopharmaceutical Oral Drug Delivery Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Biopharmaceutical Oral Drug Delivery Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Biopharmaceutical Oral Drug Delivery Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Biopharmaceutical Oral Drug Delivery Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Biopharmaceutical Oral Drug Delivery Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Biopharmaceutical Oral Drug Delivery, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Biopharmaceutical Oral Drug Delivery, Product Type & Application
  8. 3.8 Global Manufacturers of Biopharmaceutical Oral Drug Delivery, Established Date
  9. 3.9 Global Biopharmaceutical Oral Drug Delivery Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Sanofi
  2. 4.1.1 Sanofi Company Information
  3. 4.1.2 Sanofi Business Overview
  4. 4.1.3 Sanofi Biopharmaceutical Oral Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Sanofi Biopharmaceutical Oral Drug Delivery Product Portfolio
  6. 4.1.5 Sanofi Recent Developments
  7. 4.2 Novartis
  8. 4.2.1 Novartis Company Information
  9. 4.2.2 Novartis Business Overview
  10. 4.2.3 Novartis Biopharmaceutical Oral Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Novartis Biopharmaceutical Oral Drug Delivery Product Portfolio
  12. 4.2.5 Novartis Recent Developments
  13. 4.3 Novo Nordisk
  14. 4.3.1 Novo Nordisk Company Information
  15. 4.3.2 Novo Nordisk Business Overview
  16. 4.3.3 Novo Nordisk Biopharmaceutical Oral Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Novo Nordisk Biopharmaceutical Oral Drug Delivery Product Portfolio
  18. 4.3.5 Novo Nordisk Recent Developments
  19. 4.4 Pfizer
  20. 4.4.1 Pfizer Company Information
  21. 4.4.2 Pfizer Business Overview
  22. 4.4.3 Pfizer Biopharmaceutical Oral Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Pfizer Biopharmaceutical Oral Drug Delivery Product Portfolio
  24. 4.4.5 Pfizer Recent Developments
  25. 4.5 Amgen
  26. 4.5.1 Amgen Company Information
  27. 4.5.2 Amgen Business Overview
  28. 4.5.3 Amgen Biopharmaceutical Oral Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Amgen Biopharmaceutical Oral Drug Delivery Product Portfolio
  30. 4.5.5 Amgen Recent Developments
  31. 4.6 AbbVie
  32. 4.6.1 AbbVie Company Information
  33. 4.6.2 AbbVie Business Overview
  34. 4.6.3 AbbVie Biopharmaceutical Oral Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 AbbVie Biopharmaceutical Oral Drug Delivery Product Portfolio
  36. 4.6.5 AbbVie Recent Developments
  37. 4.7 Kemwell Bipharma
  38. 4.7.1 Kemwell Bipharma Company Information
  39. 4.7.2 Kemwell Bipharma Business Overview
  40. 4.7.3 Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Product Portfolio
  42. 4.7.5 Kemwell Bipharma Recent Developments
  43. 4.8 F. Hoffman-La Roche
  44. 4.8.1 F. Hoffman-La Roche Company Information
  45. 4.8.2 F. Hoffman-La Roche Business Overview
  46. 4.8.3 F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Product Portfolio
  48. 4.8.5 F. Hoffman-La Roche Recent Developments
  49. 4.9 Catalent
  50. 4.9.1 Catalent Company Information
  51. 4.9.2 Catalent Business Overview
  52. 4.9.3 Catalent Biopharmaceutical Oral Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Catalent Biopharmaceutical Oral Drug Delivery Product Portfolio
  54. 4.9.5 Catalent Recent Developments
  55. 4.10 Biocon
  56. 4.10.1 Biocon Company Information
  57. 4.10.2 Biocon Business Overview
  58. 4.10.3 Biocon Biopharmaceutical Oral Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Biocon Biopharmaceutical Oral Drug Delivery Product Portfolio
  60. 4.10.5 Biocon Recent Developments
5 Global Biopharmaceutical Oral Drug Delivery Market Scenario by Region
  1. 5.1 Global Biopharmaceutical Oral Drug Delivery Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Biopharmaceutical Oral Drug Delivery Sales by Region: 2021-2032
  3. 5.2.1 Global Biopharmaceutical Oral Drug Delivery Sales by Region: 2021-2026
  4. 5.2.2 Global Biopharmaceutical Oral Drug Delivery Sales by Region: 2027-2032
  5. 5.3 Global Biopharmaceutical Oral Drug Delivery Revenue by Region: 2021-2032
  6. 5.3.1 Global Biopharmaceutical Oral Drug Delivery Revenue by Region: 2021-2026
  7. 5.3.2 Global Biopharmaceutical Oral Drug Delivery Revenue by Region: 2027-2032
  8. 5.4 North America Biopharmaceutical Oral Drug Delivery Market Facts & Figures by Country
  9. 5.4.1 North America Biopharmaceutical Oral Drug Delivery Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2032)
  11. 5.4.3 North America Biopharmaceutical Oral Drug Delivery Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Biopharmaceutical Oral Drug Delivery Market Facts & Figures by Country
  16. 5.5.1 Europe Biopharmaceutical Oral Drug Delivery Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2032)
  18. 5.5.3 Europe Biopharmaceutical Oral Drug Delivery Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Biopharmaceutical Oral Drug Delivery Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Biopharmaceutical Oral Drug Delivery Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Biopharmaceutical Oral Drug Delivery Market Facts & Figures by Country
  41. 5.7.1 South America Biopharmaceutical Oral Drug Delivery Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2032)
  43. 5.7.3 South America Biopharmaceutical Oral Drug Delivery Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Biopharmaceutical Oral Drug Delivery Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Biopharmaceutical Oral Drug Delivery Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Biopharmaceutical Oral Drug Delivery Sales by Type (2021-2032)
  2. 6.1.1 Global Biopharmaceutical Oral Drug Delivery Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2021-2032)
  4. 6.2 Global Biopharmaceutical Oral Drug Delivery Revenue by Type (2021-2032)
  5. 6.2.1 Global Biopharmaceutical Oral Drug Delivery Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Biopharmaceutical Oral Drug Delivery Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Biopharmaceutical Oral Drug Delivery Sales by Application (2021-2032)
  2. 7.1.1 Global Biopharmaceutical Oral Drug Delivery Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2021-2032)
  4. 7.2 Global Biopharmaceutical Oral Drug Delivery Revenue by Application (2021-2032)
  5. 7.2.1 Global Biopharmaceutical Oral Drug Delivery Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Biopharmaceutical Oral Drug Delivery Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Biopharmaceutical Oral Drug Delivery Value Chain Analysis
  2. 8.1.1 Biopharmaceutical Oral Drug Delivery Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Biopharmaceutical Oral Drug Delivery Production Mode & Process
  5. 8.2 Biopharmaceutical Oral Drug Delivery Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Biopharmaceutical Oral Drug Delivery Distributors
  8. 8.2.3 Biopharmaceutical Oral Drug Delivery Customers
9 Global Biopharmaceutical Oral Drug Delivery Analyzing Market Dynamics
  1. 9.1 Biopharmaceutical Oral Drug Delivery Industry Trends
  2. 9.2 Biopharmaceutical Oral Drug Delivery Industry Drivers
  3. 9.3 Biopharmaceutical Oral Drug Delivery Industry Opportunities and Challenges
  4. 9.4 Biopharmaceutical Oral Drug Delivery Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst